glp 1 drugs and parkinson's disease GLP-1 Receptor Agonists: A New Treatment in The Emerging Role of GLP-1

Additionally, a systematic review by Drant et al

[DOI] [PubMed] [Google Scholar] 46.Ahrn B., Atkin S.L., Charpentier G., Warren M.L., Wilding J., Birch S., Holst A.G., Leiter L.A

- If the GLP-1 receptor agonist is being utilized for DMT2 management and holding a dose would impact their dosing schedule, consult the patients primary care physician or endocrinologist for bridging antidiabetic therapy to avoid hyperglycemia

G., Choi S

Genetic Predispositions That May Influence GLP-1 Response Individual genetic variants in GLP-1 receptor signaling pathways (GLP1R rs6923761), appetite regulation (FTO rs9939609, MC4R rs17782313), and GIP signaling (GIPR rs1800437) may predict predispositions toward stronger or more modest metabolic responses